Back to Search
DAVID MCDERMOTT, MD
MD
Hematology & Oncology Physician
NPI: 1033133251IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
157412(MA)
Education
JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Class of 1992
Research & Publications (20)
The application of high-dose interleukin-2 for metastatic renal cell carcinoma.
PMID 19148594·Med Oncol·2009
6-review
Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4.
PMID 19190593·Nat Clin Pract Urol·2009
8-other
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
PMID 18445842·J Clin Oncol·2008
3-trial
Interleukin-2 therapy of metastatic renal cell carcinoma--predictors of response.
PMID 17045087·Semin Oncol·2006
6-review
Interleukin-2 therapy of metastatic renal cell carcinoma: update of phase III trials.
PMID 17026799·Clin Genitourin Cancer·2006
6-review
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.
PMID 15625368·J Clin Oncol·2005
3-trial
Application of IL-2 and other cytokines in renal cancer.
PMID 15102596·Expert Opin Biol Ther·2004
6-review
Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation.
PMID 11856781·J Am Soc Nephrol·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 330 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 667-1930
Quick Facts
- NPI
- 1033133251
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile